title: Structural basis for certain naturally occurring bioflavonoids to function as reducing co-substrates of cyclooxygenase I and II.
abstract: BACKGROUND
  Recent studies showed that some of the dietary bioflavonoids can strongly stimulate the catalytic activity of cyclooxygenase (COX) I and II in vitro and in vivo, presumably by facilitating enzyme re-activation. In this study, we sought to understand the structural basis of COX activation by these dietary compounds.
  
  
  RESULTS
  A combination of molecular modeling studies, biochemical analysis and site-directed mutagenesis assay was used as research tools. Three-dimensional quantitative structure-activity relationship analysis (QSAR/CoMFA) predicted that the ability of bioflavonoids to activate COX I and II depends heavily on their B-ring structure, a moiety known to be associated with strong antioxidant ability. Using the homology modeling and docking approaches, we identified the peroxidase active site of COX I and II as the binding site for bioflavonoids. Upon binding to this site, bioflavonoid can directly interact with hematin of the COX enzyme and facilitate the electron transfer from bioflavonoid to hematin. The docking results were verified by biochemical analysis, which reveals that when the cyclooxygenase activity of COXs is inhibited by covalent modification, myricetin can still stimulate the conversion of PGG(2) to PGE(2), a reaction selectively catalyzed by the peroxidase activity. Using the site-directed mutagenesis analysis, we confirmed that Q189 at the peroxidase site of COX II is essential for bioflavonoids to bind and re-activate its catalytic activity.
  
  
  CONCLUSIONS
  These findings provide the structural basis for bioflavonoids to function as high-affinity reducing co-substrates of COXs through binding to the peroxidase active site, facilitating electron transfer and enzyme re-activation.
authors.affiliation: Department of Pharmacology, Toxicology and Therapeutics, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
authors.forename: Pan
authors.initials: P
authors.lastname: Wang
authors.forename: Hyoung-Woo
authors.initials: HW
authors.lastname: Bai
authors.forename: Bao Ting
authors.initials: BT
authors.lastname: Zhu
mesh_terms: D000818:Animals; D055162:Biocatalysis; D001688:Biological Products / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology; D051545:Cyclooxygenase 1 / Q000737:chemistry / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D004789:Enzyme Activation / Q000187:drug effects; D005419:Flavonoids / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D008968:Molecular Conformation; D016296:Mutagenesis; D010084:Oxidation-Reduction; D011485:Protein Binding; D021281:Quantitative Structure-Activity Relationship
chemical_list: D001688:Biological Products; D005419:Flavonoids; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2
references.citation: Biochim Biophys Acta. 1977 May 25;487(2):315-31
references.pmid: 405045
references.citation: Nature. 1996 Dec 19-26;384(6610):644-8
references.pmid: 8967954
references.citation: J Biol Chem. 1992 Sep 5;267(25):17649-57
references.pmid: 1517213
references.citation: J Biol Chem. 1992 Mar 25;267(9):6382-8
references.pmid: 1556140
references.citation: Free Radic Res. 2002 Nov;36(11):1219-27
references.pmid: 12592674
references.citation: Prostaglandins. 1985 Feb;29(2):175-90
references.pmid: 3920726
references.citation: Ann N Y Acad Sci. 2002 May;957:57-69
references.pmid: 12074961
references.citation: Mol Pharmacol. 1989 Nov;36(5):809-17
references.pmid: 2511429
references.citation: J Biol Chem. 1980 Jul 10;255(13):6253-61
references.pmid: 6771268
references.citation: Life Sci. 2003 Dec 5;74(2-3):143-53
references.pmid: 14607241
references.citation: J Agric Food Chem. 2001 Jun;49(6):2774-9
references.pmid: 11409965
references.citation: J Biol Chem. 1997 Aug 22;272(34):21565-74
references.pmid: 9261177
references.citation: Curr Opin Struct Biol. 2001 Dec;11(6):752-60
references.pmid: 11751058
references.citation: J Biol Chem. 2000 Sep 8;275(36):27608-14
references.pmid: 10862771
references.citation: J Lipid Res. 2008 Dec;49(12):2557-70
references.pmid: 18660529
references.citation: Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384-8
references.pmid: 1380156
references.citation: Science. 2000 Sep 15;289(5486):1933-7
references.pmid: 10988074
references.citation: J Biol Chem. 1976 May 10;251(9):2629-36
references.pmid: 816795
references.citation: J Biol Chem. 1999 Apr 2;274(14):9231-7
references.pmid: 10092596
references.citation: Biochem Pharmacol. 2008 Apr 1;75(7):1472-81
references.pmid: 18242581
references.citation: J Biol Chem. 1991 Dec 5;266(34):23261-7
references.pmid: 1744122
references.citation: Annu Rev Biochem. 2000;69:145-82
references.pmid: 10966456
references.citation: J Biol Chem. 1967 Nov 25;242(22):5344-54
references.pmid: 6070852
references.citation: Nature. 2000 May 4;405(6782):97-101
references.pmid: 10811226
references.citation: J Biol Chem. 1994 May 6;269(18):13207-15
references.pmid: 8175750
references.citation: J Biol Chem. 1996 Feb 16;271(7):3548-54
references.pmid: 8631960
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2010 Jan;82(1):45-50
references.pmid: 19897347
references.citation: Chem Biol Interact. 1988;64(3):251-66
references.pmid: 3124965
references.citation: J Invest Dermatol. 2005 Oct;125(4):818-25
references.pmid: 16185283
references.citation: Biochemistry. 1992 Oct 13;31(40):9520-5
references.pmid: 1390734
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S29-34
references.pmid: 18952571
references.citation: Eur J Biochem. 1988 Jan 15;171(1-2):321-8
references.pmid: 3123232
references.citation: Endocrinology. 2006 Sep;147(9):4132-50
references.pmid: 16728493
references.citation: Cancer Res. 2005 Oct 15;65(20):9304-11
references.pmid: 16230392